Navigation Links
The New Affymetrix GeneChip Scanner 3000

elation coefficients for other Signal comparisons (GeneChip Scanner 3000 versus GeneChip Scanner3000 and GeneArray 2500 versus GeneArray 2500 at different sites) were also as high as those listed in Table 2 (data not shown).

Figure 1 shows scatter plots generated for these analyses. The high correlation of Signal values generated by the GeneChip Scanner 3000 and the GeneArray 2500 at the same and different external sites is illustrated by plots A and B, respectively.

Percent Present Comparisons

The percent Present metric can be a useful measure of assay and instrument performance. It describes the total number of transcripts detected (called Present) out of the total number of probe sets on a probe array.

Figure 2 illustrates the average percent Present for 12 HG-U133A arrays run on each scanner type at each external site. Error bars represent one standard deviation.

The GeneChip Scanner 3000 average percent Present is statistically different from the GeneArray 2500, with the GeneChip Scanner 3000 yielding a higher average percent Present call for probe arrays run at all sites (Figure 2, *). For probe arrays run at Site 4, the GeneArray 2500 yielded a noticeably lower percent Present when compared to the GeneChip Scanner 3000 at the same site and GeneArray 2500 scanners at other sites (Figure 2, *). While the percent Present metric of the GeneArray 2500 at Site 4 appears to be different than other GeneArray 2500 scanners, it is within Affymetrix specifications and is representative of the range of GeneArray 2500 scanner performance across Affymetrix customer sites.

False Change Comparisons

False Change is a metric used to characterize reproducibility of results when scanning the same target sample hybridized to different probe arrays of the same design. False Change is defined as the frequency of the sum of Increa
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Fine Tuning Your Data Analysis: Tunable Parameters of the Affymetrix Expression Analysis Statistical Algorithms
2. The Affymetrix GeneChip Scanner 3000 New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range
3. GeneChip Sample Cleanup Module for cleanup of cDNA and in vitro transcribed cRNA
4. New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The New Affymetrix GeneChip Scanner

(Date:3/30/2015)... PMG Research, Benchmark Research, and ... formation of VaxCorps, a network of highly experienced, ... conduct of vaccine trials in healthy adult, elderly, ... successfully conducted over 500 phase I-III vaccine clinical ... influenza as well as a vast array of ...
(Date:3/30/2015)... 30, 2015  NuGene International, Inc. ("NuGene") (OTCQB: ... BioPharma, Inc. has added another internationally recognized researcher ... is an internationally recognized researcher in bio-inspired materials ... at Peking University, China , ... University of North Carolina, Chapel Hill. Following a ...
(Date:3/30/2015)... ROCKVILLE, Md. , March 30, 2015 ... company dedicated to the acquisition, development and commercialization of ... for the global market with a commercial focus on ... China Food and Drug Administration (CFDA) has approved the ... trial in ovarian clear cell carcinoma (OCCC) patients for ...
(Date:3/30/2015)... Md. , March 30, 2015  Spherix ... company committed to the fostering and monetization of ... v. VTech,  Case No. 3:13-cv-03494-M and  Spherix v. ... United States District Court for the Northern District ... update regarding Spherix v. Verizon, Case ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
... CITY, Calif., Sept. 6, 2011 Pearl Therapeutics was named ... , designating it as one of the most promising private ... Fierce 15 selection. "Pearl,s veteran team has done ... research to advance PT003 – an inhaled LAMA/LABA combination therapy ...
... SINGAPORE, Sept. 6, 2011 ImaginAb, Inc. is pleased ... subsidiary, ImaginAb Molecular Imaging Pte Ltd (IMI). IMI is ... marks a significant increase in research capability for the ... molecular imaging services to both the US parent company ...
... Mass. and TORONTO, Sept. 6, 2011 Generex Biotechnology ... as part of the Company,s reorganization plan and following ... concomitant needs assessment, the Company has completed the sales ... net cash proceeds of just over $1,000,000.  The tenanted ...
Cached Biology Technology:FierceBiotech Names Pearl Therapeutics a 2011 Fierce 15 Biotech 2FierceBiotech Names Pearl Therapeutics a 2011 Fierce 15 Biotech 3ImaginAb, Inc. Announces Formation of Singapore Subsidiary, ImaginAb Molecular Imaging Pte Ltd. 2Generex Augments Cash Position With Sales of Non-Essential Assets 2Generex Augments Cash Position With Sales of Non-Essential Assets 3
(Date:3/18/2015)... CORAL SPRINGS, Florida , March 18, 2015 ... as well as businesses, new revolutionary smart wallets and apps ... rapid pace.  Companies currently entrenched in the mobile payment industry ... ), Alibaba Group Holding Ltd. (NYSE: BABA ), ... GOOG ) and Facebook Inc. (NASDAQ: ...
(Date:3/16/2015)... HANOVER, Germany , March 16, 2015 /PRNewswire/ ... DERMALOG Identification Systems GmbH will present groundbreaking innovations ... Hanover, Germany . ... DERMALOG,s latest biometric innovation is well at ... the next generation e-gate made in ...
(Date:3/12/2015)... MOUNTAIN VIEW, Calif. , March 12, 2015 ... EDTLOCATION:Online, with Complimentary Registration here: http://bit.ly/1G7Os0L . ... Program Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... future in order to compete in several different ... the market is currently witnessing an uptrend. ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... HOUSTON (March 12, 2010) Calculations are fine, ... paper by Rice University students who decided to put to ... In 1908, the German physicist Gustav Mie came up ... of electromagnetic waves with a spherical metal particle. The theory ...
... , PITTSBURGH Carnegie Mellon University,s Matt Oberdier is developing a new hydrosurgery ... ... Mellon, said his system will be designed to help surgeons readily clear ... ...
... The usual excuse of "lack of time" for not ... in The Journal of Physiology . The ... growing evidence for the benefits of short term high-intensity interval ... types of moderate long term exercise. Astonishingly, it is possible ...
Cached Biology News:Look at Mie! 2The new exercise HIT: do less 2
DITHIOTHREITOL, 150UMOL, 1 EA. Dithiothreitol (DTT), 0.1 M Solution:, *0.1 M solution of DTT in high purity dH2O., *0.2 m filtered., *Storage: -20C. Category: SEQUENASE....
GOAT ANTI HUMAN PARAINFLUENZA VIRUS 2+3...
75 x 25 mm; sterile, recommended for immunohistochemistry of cell lines growing in suspension, Poly-D-Lysine coated, glass slides with polystyrene vessel, lid and safety removal tool...
ANTI 5-HYDROXYTRYPTOPHAN CONJ....
Biology Products: